Latest news with #WHO-GMP
News18
3 days ago
- Business
- News18
Amansa Investments pumps Rs 250 cr in Rubicon Research in pre-IPO funding round
New Delhi, Aug 14 (PTI) Amansa Investments Ltd has invested Rs 250 crore in pharma formulation firm Rubicon Research Ltd through a pre-initial public offering (IPO) funding round. As part of the transaction, General Atlantic Singapore RR Pte Ltd, one of Rubicon Research's promoters, transferred 51.60 lakh equity shares to Amansa Investments at Rs 484.47 per share, amounting to Rs 250 crore, the company said in a public announcement. At the time of filing draft papers in July 2024, General Atlantic held 8.89 crore equity shares, representing a 57.57 per cent stake. Following the pre-IPO deal, it will hold 8.37 crore equity shares, or 54.01 per cent of the company. The transaction, conducted in consultation with the book running lead managers (BRLMs) of Rubicon Research, received board approval on August 12. Other promoters of the company include Pratibha Pilgaonkar, Sudhir D Pilgaonkar, Parag S Sancheti, Surabhi P Sancheti, and Sumant S Pilgaonkar. Rubicon Research's proposed IPO consisted of a fresh issue of equity shares worth Rs 500 crore alongside an offer-for-sale of shares valued Rs 585 crore. Following the latest fundraise, the size of the fresh issue has been reduced by Rs 250 crore. The company plans to utilise proceeds from the fresh issue for payment of debt, supporting inorganic growth through unidentified acquisitions as well as other strategic initiatives and general corporate purposes. The pharma firm has two US FDA-inspected research and development (R&D) facilities, one each in India and Canada, and two manufacturing facilities in India with multiple accreditations from multiple regulatory agencies such as USFDA, Food and Drugs Administration, Maharashtra (WHO-GMP accreditation) and Health Canada. As on March 31, 2024, Rubicon Research had a portfolio of 69 products approved by the USFDA, 19 new drugs awaiting USFDA's nod and 46 products in various stages of development. PTI SP DRR view comments First Published: August 14, 2025, 12:15 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Hans India
4 days ago
- Business
- Hans India
7 Best Derma Companies in India Offering PCD Pharma Franchise Opportunities
India's skincare and dermatology sector has grown exponentially in recent years, with increasing awareness about skin health and the demand for dermatologically approved products. As this market expands, more professionals and entrepreneurs are turning to the Derma PCD pharma franchise model, a business opportunity that allows individuals to market and distribute high-quality skincare products with regional monopoly rights. If you're looking to partner with the best derma company in India, here's a list of seven reputable companies offering PCD franchise opportunities. These brands are known for their product quality, support systems, and franchise-friendly business models. 1. Gary Pharma – Trusted Name in Dermatology Gary Pharma ranks among the best derma companies in India, known for its commitment to quality, science-backed formulations, and ethical business practices. With a robust portfolio of over 100+ DCGI-approved derma skin care products, the company manufactures everything from creams, serums, and ointments to lotions, shampoos, tablets, and capsules all produced in WHO-GMP certified units. Their Derma PCD pharma franchise program offers: Monopoly rights across regions Marketing and promotional support High margins & timely delivery Full partner training and business support If you're planning to enter or expand in the derma segment, Gary Pharma offers a dependable and scalable partnership model. 2. Mankind Pharma – High Brand Recall with Broad Portfolio Mankind Pharma is a household name in India's pharmaceutical landscape. With a growing derma division, they offer prescription and cosmeceutical skincare products under sub-brands like Acnestar and Healol. While their franchise onboarding is selective, their market trust and advertising muscle make them a valuable name to align with. 3. Glenmark Pharmaceuticals – Dermatology Expertise Glenmark has a strong presence in dermatology, especially in therapeutic segments like anti-fungal and acne treatments. Their derma products are often recommended by dermatologists across India. Though not a conventional PCD brand, their co-marketing and partner-based distribution strategies are worth exploring. 4. Zydus Lifesciences (Zydus Derma Division) A leading pharmaceutical conglomerate, Zydus has a dedicated derma segment offering prescription-based solutions for psoriasis, acne, and fungal infections. Their derma franchise or distribution programs operate on a more structured and high-volume model, ideal for large-scale distributors. 5. Intas Pharmaceuticals – Strong R&D and Derma Range Intas is known for its innovation-led approach and offers several specialized products under its dermatology division. Their franchise engagement typically comes via channel partners, but their brand equity and portfolio strength in skincare and haircare is unmatched. 6. Abbott India – Premium Dermatology Focus Abbott brings global credibility with its derma line focused on anti-aging, acne, and pigmentation disorders. Though not a traditional PCD player, their partner network allows localized distribution with premium product offerings. Ideal for those targeting high-end clinics and dermatologist channels. 7. Torrant Pharma – Cosmetology Backed by Clinical Excellence Torrant Pharma has a growing portfolio in dermatology and cosmetology with formulations targeting melasma, acne, and dermatitis. Their PCD model supports ethical distribution with a balanced mix of oral and topical products, and they're actively expanding across Indian states. Final Words Whether you're a pharma distributor, a seasoned professional, or a first-time entrepreneur, the derma PCD pharma franchise model is a low-risk, high-demand business opportunity. These seven companies represent a mix of legacy pharmaceutical giants and emerging leaders in dermatology. For those looking for both quality products and strong franchise support, Gary Pharma stands out as the ideal choice, combining pharma-grade skincare, regulatory trust, and long-term business viability.
Time Business News
23-07-2025
- Business
- Time Business News
How to Start a PCD Pharma Franchise in Chandigarh: A Step-by-Step Guide
Chandigarh, one of North India's most planned cities, has become a hotspot for pharmaceutical businesses, especially in the PCD (Propaganda Cum Distribution) model. With increasing healthcare demands and government support for pharma businesses, many aspiring entrepreneurs are exploring the opportunity to partner with a PCD pharma franchise company in Chandigarh. One such reputable name in the region is Biomax Biotechnics, known for its high-quality medicines, WHO-GMP certified facilities, and extensive product range. If you're considering starting a PCD Pharma Franchise in Chandigarh, this detailed guide will walk you through the essential steps. Before diving in, it's crucial to understand what a PCD Pharma Franchise is. In this model, a pharma company allows an individual or distributor to sell its products in a specific area with exclusive marketing and distribution rights. A PCD pharma company in Chandigarh like Biomax Biotechnics provides products, promotional material, and full support, while the franchisee handles local distribution and sales. Chandigarh has a competitive pharmaceutical market. To stand out, you must study demand trends, competitor strategies, and product gaps. Choose a niche such as general medicine, pediatrics, gynecology, or dermatology based on your interests and market potential. This will help you select a PCD Pharma Franchise Company in Chandigarh that specializes in your preferred segment. Your business success heavily depends on the pharma company you partner with. Look for the following criteria: Product Range : Ensure the company offers a wide and quality-assured range of medicines. : Ensure the company offers a wide and quality-assured range of medicines. Certifications : Choose companies with WHO-GMP and ISO certifications. : Choose companies with WHO-GMP and ISO certifications. Monopoly Rights : Check if they offer area-wise monopoly distribution rights. : Check if they offer area-wise monopoly distribution rights. Marketing Support: Evaluate their promotional tools and sales support. Reliable companies like Biomax Biotechnics are known for transparent dealings, prompt delivery, and strong support to their franchise partners. To operate legally, you'll need: Drug License Number : Issued by the State Drug Control Department. : Issued by the State Drug Control Department. GST Registration : Required for tax compliance and billing. : Required for tax compliance and billing. Agreement with Pharma Company: A formal franchise agreement that mentions the terms, area rights, product list, and pricing. These documents are essential for starting any PCD Pharma Franchise in Chandigarh. Starting a franchise doesn't require a huge investment. Depending on the product range and company policies, you can begin with a modest investment. However, you must plan for: Product stock Storage facility (clean and temperature-controlled) Basic office setup Transport and logistics arrangements Make sure your infrastructure aligns with the standards required by the PCD Pharma Company in Chandigarh. Once you launch your franchise, focus on building relationships with local doctors, clinics, and retailers. Use the promotional material provided by the company—like visual aids, MR bags, brochures, and product samples—to spread awareness. Online platforms, medical camps, and local marketing can help grow your presence. Starting a PCD Pharma Franchise in Chandigarh is a smart business decision for those looking to enter the pharmaceutical sector with minimal risk and strong support. With the right partner, proper planning, and a focus on customer satisfaction, you can build a profitable and sustainable venture. Biomax Biotechnics, a trusted PCD Pharma Franchise Company in Chandigarh, offers everything you need—from top-quality products to unmatched franchise support. Take the first step today and become a part of India's booming pharma industry. TIME BUSINESS NEWS
Fashion Value Chain
15-07-2025
- Health
- Fashion Value Chain
Medkart Champions Generic Drug Quality Amid Rising Consumer Concerns
With growing scrutiny around the quality and reliability of generic medicines in India, Medkart, Gujarat's largest generic-first pharmacy chain, is stepping forward to assure patients that affordability does not mean compromise. In response to increasing consumer concerns, the company has reinforced its Medkart Assured program-rooted in audit-based sourcing, Schedule M compliance, and continuous recertification. Medkart audit team ensuring WHO-GMP and Schedule M compliance for Assuring quality 'Price matters-but quality is non-negotiable. Medkart ensures every medicine on our shelves not only saves you money but also meets India's highest manufacturing and safety standards,' said Ankur Agarwal, Co-founder of Medkart. The Generic Dilemma: Cost vs. Confidence India's generic drug market, valued at over USD 24 billion as per Invest India, continues to face consumer trust issues domestically. A 2025 study published in the European Journal of Clinical Pharmacology reported that patients often harbour doubts about the safety and effectiveness of generics, particularly in oncology and cardiovascular segments. The study emphasizes that inconsistent communication by healthcare providers and a lack of robust manufacturer-level visibility are key barriers to trust. Moreover, WHO-backed reviews have highlighted that enforcement of quality regulations-especially in smaller manufacturing units-is uneven, contributing to a fragmented trust ecosystem. These systemic challenges, combined with low awareness and historical overreliance on branded drugs, reinforce the incorrect perception that affordability comes at the cost of efficacy. What Is Schedule M-and Why It Matters To combat this, Medkart has aligned all its procurement processes with Schedule M of the Drugs and Cosmetics Act-a stringent regulatory guideline that specifies Good Manufacturing Practices (GMP) for pharmaceutical production. Schedule M, as outlined by the Indian Pharmaceutical Alliance (Schedule M-1 Guidelines), covers standards for equipment, hygiene, storage, testing, and documentation-ensuring that every medicine manufactured is traceable and safe for consumption. Medkart Assured: Going Beyond Certification Medkarts multi-layered quality assurance process includes: Plant Audits : Medkart independently conducts regular plant audits of all partnered manufacturers to ensure international quality norms. Compulsory Dual Testing : Quality checks are run twice on all products at NABL accredited third-party labs to monitor consistency. Medkart Assured Tag: Only after passing all quality thresholds is a product marked 'Medkart Assured' in-store and online. 'We've built Medkart Assured so patients never have to choose between affordability and safety,' said Parasharan Chari, Co-founder of Medkart. 'Our commitment to Schedule M compliance, independent audits, and third-party testing gives consumers confidence that every medicine they take is backed by rigorous validation.' Raising the Bar on Public Trust In an ecosystem where trust is as important as pricing, Medkart's dual focus on education and assurance is helping reshape public opinion. The Medkart app includes a powerful Medicine-to-Medicine comparison tool, enabling users to make informed decisions with ease. Pharmacists are trained not just to dispense but to explain quality differences and clear doubts. Download With Confidence Patients deserve affordability without anxiety. Visit or download the Medkart App on-Play Store or App Store to compare medicines, upload prescriptions, and order Medkart Assured medicines-generic, yes, but never second best.
Hans India
05-06-2025
- Health
- Hans India
AB-PMJAY, Jan Aushadhi Kendras boosting healthcare for middle class in last 11 years
New Delhi: Flagship scheme like the Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) and the Jan Aushadhi Kendras under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) has significantly enhanced healthcare for middle class in the last 11 years, according to an official statement issued on Thursday. 'Healthcare in India has seen a quiet but far-reaching shift in the last eleven years. Through a blend of targeted public schemes and digital reach, the Government has made quality healthcare both affordable and accessible for millions, especially the middle class,' the statement said. With more than 41.02 crore Ayushman Cards created in 33 States and Union Territories, as of May 30, AB-PMJAY has emerged as one of the world's largest publicly funded health assurance schemes. The scheme has enabled 8.59 crore hospital admissions worth Rs 1,19,858 crore, ensuring access to secondary and tertiary care without pushing families into debt, the statement said. Further, with the number of Jan Aushadhi Kendras rising to 16,469, as of May 30, from just 80 in 2014, the PMBJP brought essential medicines within reach of the common citizen. These outlets offer medicines that cost 50 to 80 per cent less than branded options, with strict quality standards ensured through WHO-GMP certified suppliers. The scheme serves around 10 to 12 lakh people daily, and cumulative savings over the last eleven years are estimated to be more than Rs 38,000 crore, the statement said. The product range now includes 2,110 medicines, including for chronic conditions like diabetes or heart disease, and 315 surgical products, covering all major treatments, cutting down financial stress for millions of families, especially the middle class. 'From free hospitalisation for senior citizens to low-cost medicines available nationwide, people today have better control over their health expenses. The digital backbone supporting these schemes has made enrolment, access, and tracking easier than ever. This change has allowed the middle class to benefit from savings on medicines, timely treatment, and greater medical security without bureaucratic hassles,' the statement said. 'Over the past eleven years, the government has shown unwavering commitment to uplifting the middle class in meaningful ways. The policies and reforms introduced have not only eased everyday challenges but also strengthened financial security, housing, healthcare, and skill development,' it added.
